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Post-translational modifications and correct subcellular localization of viral structural proteins
are prerequisites for assembly and budding of enveloped viruses. Coronaviruses, like the severe
acute respiratory syndrome-associated virus (SARS-CoV), bud from the endoplasmic reticulum
Golgi intermediate compartment. In this study, the subcellular distribution and maturation of
SARS-CoV surface proteins S, M and E were analysed by using C-terminally tagged proteins.
As early as 30 min post-entry into the endoplasmic reticulum, high-mannosylated S assembles
into trimers prior to acquisition of complexN-glycans in the Golgi. Like S, M acquires high-mannose
N-glycans that are subsequently modified into complex N-glycans in the Golgi. The
N-glycosylation profile and the absence of O-glycosylation on M protein relate SARS-CoV to
the previously described group 1 and 3 coronaviruses. Immunofluorescence analysis shows that
S is detected in several compartments along the secretory pathway from the endoplasmic
reticulum to the plasma membrane while M predominantly localizes in the Golgi, where it
accumulates, and in trafficking vesicles. The E protein is not glycosylated. Pulse-chase labelling
and confocal microscopy in the presence of protein translation inhibitor cycloheximide revealed
that the E protein has a short half-life of 30 min. E protein is found in bright perinuclear patches
colocalizing with endoplasmic reticulum markers. In conclusion, SARS-CoV surface proteins S,
M and E show differential subcellular localizations when expressed alone suggesting that
additional cellular or viral factors might be required for coordinated trafficking to the virus
assembly site in the endoplasmic reticulum Golgi intermediate compartment.
INTRODUCTION
Virus particle assembly and budding is the last step of the
virus life-cycle. It requires correct folding and post-
translational modifications of structural proteins and their
precise subcellular localization at the virus budding site.
Assembly and budding of the recently identified severe
acute respiratory syndrome coronavirus, SARS-CoV, (Kuiken
et al., 2003; Peiris et al., 2003) is a complex process that
requires coordinated maturation and trafficking of the four
structural proteins, the nucleocapsid (N), the Spike (S),
the membrane (M) and the envelope (E) proteins. Little is
known about SARS-CoV membrane proteins trafficking
and function. By analogy with other animal and human
coronaviruses it is assumed that SARS-N protein forms a
ribonucleoprotein complex with RNA, which buds into
the membrane of an endoplasmic reticulum Golgi inter-
mediate compartment (ERGIC) where the surface proteins
S, M and E need to be located for virus budding.
Protein glycosylation is a highly regulated process that
plays a fundamental role in membrane protein folding,
oligomerization, sorting and transport by the intracellular
machinery (Helenius & Aebi, 2001). The S protein is a
150–180 kDa highly glycosylated trimeric class I fusion
protein (Bosch et al., 2003; Delmas & Laude, 1990; Tripet
et al., 2004) responsible for receptor binding (Delmas et al.,
1992; Williams et al., 1991; Yeager et al., 1992), virus-
membrane fusion and tissue tropism of coronaviruses
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(Laude et al., 1993). The SARS-S protein can use angiotensin
converting enzyme 2 (ACE2) to enter cells and elicits a
neutralizing antibody response in animals (Li et al., 2003;
Simmons et al., 2004; Wong et al., 2004; Yang et al., 2004a,
b). In some coronaviruses, S is cleaved into subunits S1
and S2 by subtilisin endoproteases resulting in an increa-
sed fusogenic activity (de Haan et al., 2004; Taguchi, 1993).
M is a glycosylated hydrophobic protein with three trans-
membrane domains bearing N- or O-glycosylation site at
the N terminus (de Haan et al., 2003; Escors et al., 2001b;
Klumperman et al., 1994). It is the most abundant protein
in the virion and thought to play a key role in organizing
particle assembly (de Haan et al., 2000).When co-expressed,
M and E proteins of several animal coronaviruses includ-
ing transmissible gastroenteritis virus (TGEV; Baudoux
et al., 1998a), mouse hepatitis virus (MHV; Bos et al., 1996;
Vennema et al., 1996) or infectious bronchitis virus (IBV;
Lim & Liu, 2001) can form viral particles even in the absence
of N or S protein. Although E is implicated in virus particle
formation it is only found at low levels in particles (Corse &
Machamer, 2000; Fischer et al., 1998; Vennema et al., 1996).
While the budding site of several coronaviruses has been
localized at the ERGIC (Klumperman et al., 1994), the viral
surface proteins can be found in downstream compartments
of the secretory pathway when expressed by the virus or
alone: M localizes predominantly in the Golgi apparatus
(Escors et al., 2001a; Locker et al., 1994, 1995; Machamer
et al., 1990, 1993; Swift & Machamer, 1991), and S is found
along the secretory pathway and at the plasma membrane
(de Haan et al., 1999; Lontok et al., 2004; Opstelten et al.,
1995), while E is detected in perinuclear regions, the ER
and Golgi (Corse & Machamer, 2003; Lim & Liu, 2001;
Raamsman et al., 2000). Coronavirus proteins acquire
modifications of their N-glycans in Golgi compartments,
which might play an important role in the virus life-cycle.
Indeed N-glycans of viral receptor binding proteins like S
play a role in virus binding to lectin receptor DC-SIGN
(dendritic cell-specific ICAM-grabbing non-integrin) on
dendritic cells (Lin et al., 2003; Lozach et al., 2004) or
shielding neutralizing epitopes from antibody recognition
(Wei et al., 2003). On the other hand the glycan attached to
the M protein is implicated in interferon (IFN)-a induction
and in vivo replicative capacity (Baudoux et al., 1998b;
de Haan et al., 2003).
The present work describes the differential maturation,
post-translational glycosylation profile and subcellular
localization of human coronavirus, the SARS-CoV surface
proteins S, M and E.
METHODS
Plasmid constructions. SARS-M and -E cDNAs were cloned from
the strain HKU-39849 isolated from a SARS case in Hong Kong
(Peiris et al., 2003; Tsang et al., 2003), and amplified by PCR with
primers containing BssHII and NsiI adaptor sites. The DNA
sequence encoding the M2-FLAG peptide (DYKDDDDK) was
included within the reverse primers for in-frame fusion in the 39
end (M forward primer: 59-ATATGCGCGCATGGCAGACAACG-
GTACTATTACCGTTGAG-39; M reverse primer: 59-TTGCATG-
CATTTACTTGTCATCGTCATCCTTGTAGTCATCCTGTACTAGC-
AAAGCAATATTGTCG-39; E forward primer: 59-ATATGCGCGC-
ATGTACTCATTCGTTTCGGAAG-39; E reverse primer: 59-TTG-
CATGCATTTACTTGTCATCGTCATCCTTGTAGTCATCGACCAG-
AAGATCAGGAACTC-39). SARS-M and E-FLAG PCR fragments
were cloned into the pSFV1 vector (Invitrogen) resulting in plasmids
pSFV-M-FLAG and pSFV-E-FLAG. SARS-S cDNA was obtained
directly from the RNA extracted from a BAL specimen (#031589)
from a SARS case of the Hanoi French Hospital, Vietnam. After
reverse transcription, overlapping S cDNA fragments were produced
by nested PCR and cloned in plasmid PCR 2.1-TOPO (Invitrogen)
using the following primers: S/F1/+/21350–21372 with S/R1/2/
23518–23498 followed by S/F2/+/21406–21426 with S/R2/2/23454–
23435 for the 59-proximal fragment, and S/F3/+/23258–23277 with
S/R3/2/25382–25363 followed by S/F4/+/23322–23341 with S/R4/
2/25348–25329 for the 39-proximal fragment. A cDNA fragment
representing the complete S gene sequence (nt 21406–25348) was
next assembled from clones with overlapping S cDNA fragments
harbouring the consensus protein sequence as deduced by direct
sequencing of the amplicons from specimen #031589. The resulting
plasmid TOP10F9-SARS-S was used as the source of S cDNA for
subsequent cloning. SARS-S cDNA was amplified by PCR with
primers containing BssHII and ApaI adaptor sites. The DNA
sequence encoding the M2-FLAG peptide was included within the
reverse primer (forward primer: 59-ATATGCGCGCATGTTTATTT-
TCTTATTATTTCTTAC-39; reverse primer: 59-ATATGGGCCCA-
CCACCATCGATTGTGTAATGTAATTTGACACCCTTGAGAAC-39).
Alternatively, for improved expression codon-optimized SARS-S
DNA was produced using GeneOptimizer Technology (Geneart),
with a FLAG sequence in-frame at the 39 end. S-FLAG was sub-
cloned into pSFV1 vector resulting in plasmid pSFV-S-FLAG. SARS-
S, -M and E-EGFP or ECFP (enhanced green or cyan fluorescent
protein; BD Biosciences) constructs were also produced. ClaI-FLAG-
ApaI sequences from pSFV-S, M, E-FLAG constructs were replaced
with EG/CFP fragments produced by PCR with ClaI and ApaI sites-
containing primers (forward primer: 59-ATACATCGATATGGTGA-
GCAAGGGCGAGGAG-39; reverse primer: 59-ATATGGGCCCTTA-
CTTGTACAGCTCGTCC-39). The pEYFP-Golgi plasmid construct
encoding the Golgi targeting sequence of b-1,4-galactosyltransferase
fused to EYFP (enhanced yellow FP) fluorescent tag was obtained
from BD Biosciences.
Cells, SFV expression vector and antibodies. The baby
hamster kidney (BHK)-21 cell line was cultured at 37 uC, 5% CO2,
in Glasgow minimum essential medium (GMEM) medium, 5% fetal
calf serum (FCS), 20 mM HEPES, 10% tryptose-phosphate broth,
100 U penicillin ml21, 100 mg streptomycin ml21.
Recombinant defective SFV particles were made as described
previously (Staropoli et al., 2000). Briefly, plasmids pSFV-helper2,
pSFV-S, -M, E-FLAG were linearized by SpeI, purified and in vitro
transcribed using SP6 Cap-Scribe RNA polymerase (Roche). pSFV-
helper2 and pSFV-S, -M or E-FLAG derived capped RNAs were
mixed in equal amounts and electroporated into BHK-21 cells. After
24 h, the supernatant containing the recombinant SFV particles
was harvested, and particles were purified and activated to infect
BHK-21 cells.
The following antibodies and sera were used: SARS convalescent
patient sera C0, SARS patient convalescent C1 to C7 and acute A1 to
A7 sera (both provided by M. Peiris, Microbiology department,
Hong Kong University); human normal sera N1 to N10 (Red Cross
of Hong Kong, 1999–2000); horse radish peroxidase (HRP)- and
fluorescein (FITC)-coupled mouse IgG1 anti-FLAG M2 monoclonal
antibodies (mAbs) (Sigma); anti-human ACE2 ectodomain mouse
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IgG2a mAbs (R&D system); anti-Erp72 rabbit polyclonal Abs
(Stressgen), anti-ERGIC-53 mouse IgG1 mAbs (provided by
P. Hauri, Dept of Pharmacology/Neurobiology, University of Basel,
Switzerland), anti-58K mouse mAbs (Abcam). HRP- and FITC-
coupled goat anti-mouse and anti-human IgG secondary Abs were
obtained from Zymed.
Pulse-chase analysis. BHK-21 cells were starved at 37 uC for
30 min in methionine- and cysteine-free DMEM (Gibco-BRL), 12 h
after transfection. Cells were pulse-labelled with 0?3 mCi (12?3 MBq)
35S-labelled methionine and cysteine (Promix; Amersham Bio-
sciences) at 37 uC for 10 min, washed with unlabelled methionine
and cysteine containing GMEM (Gibco-BRL) with 2% FCS,
followed by incubation with this medium without FCS at 37 uC for
30 min to 12 h chase times.
Reactions were stopped by rinsing cells with chilled PBS and incuba-
tion on ice. Cells were lysed with lysis buffer (20 mMTris/HCl pH 7?5,
150 mM NaCl, 2 mM EDTA, 1% Triton X-100) containing 5 mM
PMSF (Roche Applied Sciences), cells debris were cleared by centri-
fugation and supernatants were immunoprecipitated with anti-FLAG
M2 agarose affinity gel according to manufacturer’s protocol (Sigma).
Immunoprecipitated proteins were mixed with sample loading buffer
containing 50 mM DTT and separated by 4–20% (for E and M) or
4–12% (for S) SDS-PAGE. Images were acquired by exposure to
phosphoimager (Molecular Imager Fx; Bio-Rad).
Endoglycosidase H (EndoH) and peptide-N-glycosidase F
sensitivity assays. Immunoprecipitated radiolabelled S or M
proteins were washed twice in PBS, denatured in 0?5% SDS and 1%
b-mercaptoethanol at 100 uC for 5 min, and incubated overnight
at 37 uC in 10 mM sodium phosphate buffer pH 5?8 containing
EndoH (5 mU; Roche Applied Sciences) or pH 7?6 with 1?2%
Triton X-100 containing peptide-N-glycosidase F (2 U; Roche,
Applied Sciences). Reactions were stopped with sample loading
buffer containing 50 mM DTT.
Flow cytometry analysis. BHK-21 cells were detached 20 h post-
infection (p.i.) using 2 mM EDTA in PBS, washed, and stained for
45 min at 4 uC with 1 : 50 dilution of SARS patient serum in PBS
containing 3% goat serum (GS). After washing, cells were labelled
with FITC-conjugated anti-human IgG Abs for 30 min and analysed
using a FACSCalibur (BD Biosciences). Mean of fluorescence
intensity (MFI) was measured after labelling with fluorochrome-
conjugated Abs.
ACE2 co-immuniprecipitation assay. Recombinant S–FLAG or
E. coli bacterial alkaline phosphatase (BAP)–FLAG (Sigma) proteins
previously pre-adsorbed onto M2 affinity gel beads (Sigma) for 2 h
at 4 uC were incubated with soluble recombinant ACE2 protein
(R&D Systems) for 2 h at 4 uC. Beads were washed four times with
lysis buffer (20 mM Tris/HCl pH 7?5, 150 mM NaCl, 2 mM EDTA,
1% Triton X-100). Precipitates were separated by SDS-PAGE,
blotted and detected with HRP-conjugated mouse IgG2a anti-ACE2
ectodomain or mouse anti-FLAG M2 mAbs.
Subcellular localization by fluorescence microscopy. Cells
were grown on coverslips, fixed 6–15 h p.i. in 4% paraformaldehyde
(in PBS) for 15 min, incubated in 50 mM NH4Cl (in PBS) for
10 min at room temperature and permeabilized in 0?1% Triton X-
100 (in PBS) for 5 min. Cells previously incubated for 30 min at
room temperature in PBS containing 10% GS were labelled for 1 h
with primary Abs in PBS containing 5% GS, washed and stained
with dye-conjugated secondary Abs for 1 h. Coverslips were then
washed and mounted on slides using Mowiol mounting medium
containing DABCO (Sigma) prior to analysis by confocal micro-
scopy (Bio-Rad Radiance 2100). For time-lapse microscopy on
living cells, BHK-21 cells were grown on glass bottom microwell
dishes (MatTek Corporation). Before analysis, culture medium was
changed to Hanks’ balanced salts solution, 10 mM HEPES, 0?16
Optimem buffer (Gibco-BRL). Living cells were analysed under an
Axiovert 200M microscope related to the AxioVision system (Zeiss)
and images were acquired with intervals of 10 s.
RESULTS
Expression of S, M and E as C-terminal fusion
proteins with the FLAG peptide and fluorescent
proteins
We analysed the expression, glycosylation maturation
profile and kinetics of SARS-S, -M and -E surface pro-
teins folding in mammalian cells. All three proteins were
expressed as C-terminal fusion proteins with the FLAG
peptide (Lozach et al., 2003), the GFP, or EGFP or ECFP
(Yang et al., 1996) using the defective Semliki Forest virus
system (Liljestrom & Garoff, 1991).
SARS-S N-glycan modification and
oligomerization
We performed metabolic labelling and pulse-chase experi-
ments to analyse the maturation profile of the SARS-S
protein, a 1255 aa protein that contains 23 putative N-
glycosylation sites (Fig. 1). For pulse-chase experiments,
mock controls are shown in Supplementarymaterial, Fig. S1
(in JGV Online). S–FLAG protein is first detected as a
monomer with the apparent molecular mass of 170 kDa
[Fig. 1a (*), 0 h of chase]. As shown by its sensitivity to
EndoH, the 170 kDa protein is N-glycosylated in the ER
with high-mannose N-glycans (Fig. 1b, 0 h of chase). At
0?5 h post-chase a second EndoH-resistant but peptide-N-
glycosidase F (PNGaseF)-sensitive S with the apparent
molecular mass of 180 kDa appears (#) (Fig. 1a, b). The
EndoH resistance reflects the conversion of high-mannose
to complex type N-glycans in the cis to medial Golgi. The
180 kDa protein signal increases over time while the
170 kDa protein band diminishes in intensity from 1 h
post-chase but still remains detectable at 12 h. These results
indicate that a significant portion of SARS-S is retained in
the ER while protein undergoes an efficient maturation
resulting in its release from the quality control machinery
and exit from the ER.
High molecular mass forms of S, with an apparent mole-
cular mass of~600 kDa, can be detected as early as 30 min
post-entry into the ER (Fig. 1c). A double band can be
detected at 1 h post-chase (Fig 1c, # and <), which likely
corresponds to high-mannose and complex glycosylated
S oligomers, respectively. This result suggests that high-
mannose N-glycans on S oligomers have been modified to
complex N-glycans. The majority of ~600 kDa forms of S
dissociates into monomers under heating in non-reducing
conditions, suggesting that S oligomers do not correspond
to covalently linked aggregates but to correctly folded S-
associated proteins (Supplementary Fig. S2 in JGV Online).
Based on our results and previous data on coronavirus S
proteins we conclude that SARS-S is a trimer.
%paper no. vir80671 charlesworth ref: vir56967&
http://vir.sgmjournals.org 3
SARS-CoV surface protein maturation
Additional protein species with molecular mass below
150 kDa were also detected by Western blotting, suggesting
that they might be putative S1 and S2 subunits of S pro-
tein. In our pulse-chase experiments however these small
proteins could only be detected at early time points and
progressively disappeared after 30 min of chase. We there-
fore conclude that low molecular mass-proteins correspond
to degradation products of misfolded SARS-S protein,
which has not passed the ER quality control machinery.
Purified recombinant SARS-S protein is
recognized by SARS patient sera and binds
soluble ACE2
In order to assess the correct folding of the recombinant
SARS-S we analysed the recognition of cell surface-
expressed S–FLAG by a panel of SARS patient sera and its
binding capacity to the ACE2 receptor (Fig. 2). First, we
used flow cytometry analysis to determine the efficiency of
recognition of cell surface expressed S by human sera
(Fig. 2a). We considered the value of geometric MFI, to
evaluate serum reactivity. As a positive control, we tested a
SARS patient serum (C0) that has previously been shown
to be strongly reactive against S (Woo et al., 2004). The MFI
obtained for C0 serum was 98?5. All 11 convalescent SARS
patient sera (C1 to C11) tested recognized cells expressing S
with MFI ranging from 31?8 to 103?9 (mean value of 62?4).
Eleven sera from normal blood donors were also tested
and the mean value of MFI was 12?1. These data show that
recombinant SARS-S is recognized by sera from convales-
cent SARS patients but not by sera from uninfected subjects.
ACE2 is a functional SARS-CoV receptor for virus entry
(Li et al., 2003; Wang et al., 2004). We studied the inter-
action between immunopurified recombinant S–FLAG
coated on Sepharose beads and purified soluble ACE2.
Fig. 2(b) shows that recombinant SARS-S, but not a control
protein, BAP–FLAG, binds efficiently to the SARS-CoV
receptor.
Altogether, these data suggest that the recombinant S
produced in mammalian cells with the SFV expression
system acquired a native-like fold that allows its recogni-
tion by SARS patient sera as well as binding to its
physiological receptor ACE2.
SARS-M protein is N-glycosylated
SARS-M is a 221 aa protein with a single potential N-
glycosylation site and three potential O-glycosylation sites.
Three major forms of M could be detected on SDS-PAGE
after immunoprecipitation of extracts from pulse-labelled
cells (Fig. 3a, see Supplementary Fig. S1 in JGV Online for
mock control). The most abundant form of M migrates
with an apparent molecular mass of 22 kDa (*) and carries
EndoH and PNGaseF-sensitive high-mannose N-glycans
(Fig. 3b and c; 0, 0?5 and 1 h of chase). It is strongly detected
until 1 h post-synthesis but only weakly at 3 h. The decrease
in the 22 kDa M coincides with the gradual increase
of a heterogeneous population of M protein migrating at
30–50 kDa (#) following 30 min post-synthesis. The 30–
50 kDa protein forms carry complex N-glycans demon-
strated by their resistance to EndoH (Fig. 3b) and sensitivity
to PNGaseF (Fig. 3c). These results strongly indicate that
the highly mannosylated 22 kDa M protein exits the ER
and proceeds to the Golgi apparatus where it acquires
modifications of its single N-glycan. Treatment of the
22 kDa or the 30–50 kDa M protein with O-glycosidase
did not yield any band shift suggesting that SARS-M is not
O-glycosylated (data not shown).
A stable protein of an apparent molecular mass of 18 kDa
(n) was detected throughout the time course of the
experiment. This protein did not undergo size shift and was
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Fig. 1. SARS-S protein can mature into an EndoH resistant complex glycoform within 30 min following expression. BHK-21
cells were transfected with SARS-S encoding RNA and starved 12 h post-transfection at 37 6C for 30 min in methionine- and
cysteine-free medium. Cells were pulse-labelled for 10 min in medium complemented with 0?3 mCi 35S-labelled methionine
and cysteine amino acids and chased for increasing times before lysis. SARS-S proteins were immunoprecipitated from cell
lysates with M2 mAb directed against the FLAG tag and analysed by SDS-PAGE and gel exposure to a phosphoimager
screen. (a) Cells were chased for 0, 0?5, 1, 3, 6 and 12 h before harvest. (b) Cells were treated as in (a) and
immunoprecipitated SARS-S was exposed to EndoH treatment. (c) Cells were treated as in (a) and immunoprecipitated
SARS-S were run for longer time onto a SDS-PAGE to separate better SARS-S bands. *, 170 kDa EndoH-sensitive S
glycoform; #, 180 kDa EndoH-resistant S glycoform; +, 150 kDa EndoH-processed S glycoform; <, EndoH-sensitive S
trimer; #, EndoH-resistant S trimer.
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not susceptible to EndoH, PNGaseF (Fig. 3b, c) or O-
glycosidase treatment (data not shown) indicating that
neither O- nor N-glycosylation sites on the 18 kDa M
protein are used. Similar to S, polypeptides with a lower
than the calculated molecular mass of M–FLAG could be
immunoprecipitated at early time points (Fig. 3). Expres-
sion of these polypeptides decreased at 1 h post-synthesis
and became undetectable at 3 h suggesting that they
represent degradation products of misfolded M proteins,
which did not pass the ER quality control.
SARS-E is not glycosylated and is rapidly
degraded
SARS-E is a small 76 aa protein without potential N-
glycosylation sites. E–FLAG migrates on SDS-PAGE with
an apparent molecular mass of 10 kDa as a doublet of
two very close bands (Fig. 4, see Supplementary Fig. S1 for
mock control). This indicates a potential post-translational
modification of the protein. The doublet was only dis-
tinguishable in experiments performed with long runs of
efficiently expressed E protein samples in SDS-PAGE. Time
course pulse-chase labelling performed 12 h p.i. revealed
that E–FLAG protein has a half-life of 30 min (determined
by quantification of E signals after phosphoimager expo-
sure, not shown). The protein disappears gradually 1 h
post-synthesis and is only weakly detected at 6 h (Fig. 4).
Analysis of culture supernatants by immunoprecipitation
with anti-FLAG M2 mAbs or nuclei by immunofluores-
cence did not show any evidence of secretion or nuclear
localization of E. We conclude that E has intrinsic pro-
perties leading to rapid degradation. Confocal microscopy
analyses in the presence of cylcoheximide further confirmed
this conclusion (see below).
SARS-S glycoprotein is detected along the
secretory pathway
The subcellular localization of individually expressed SARS-
S protein was studied in SFV-S-infected mammalian cells
by immunofluorescence and confocal laser microscopy.
We performed co-labelling studies with organelle markers
by taking advantage of both S–FLAG and S–GFP fusion
proteins that have similar distributions (Fig. 5). At 6 h
p.i., when SFV-derived protein expression is still weak
(Liljestrom & Garoff, 1991), S–FLAG showed a predomi-
nantly ER-restricted pattern which overlapped the ER-
resident protein Erp72 staining. At 15 h p.i., in addition to
its colocalization with Erp72, S–FLAG was also detected in
distinct bright dots throughout the cytoplasm and at the
plasma membrane. We analysed further whether S localized
in the ERGIC or Golgi by co-labelling S–GFP-expressing
cells with resident proteins of these organelles, ERGIC-53
and Golgi-58K, respectively. As shown in Fig. 5, at 12 h p.i.
S–GFP was detected throughout the cytoplasm with an ER
characteristic pattern as well as in brighter perinuclear
patches which colocalized with Golgi-58K and partially
with ERGIC-53 (Fig. 5).
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Fig. 2. Recombinant S is recognized by convalescent SARS
patient sera and interacts with ACE2 in vitro. (a) SFV-S-
infected BHK-21 cells were harvested 20 h p.i. and labelled
with human sera (1 : 50), then detected with a goat secondary
antibody anti-human IgG coupled to fluorescein (FITC). White
histograms: normal human serum; black histograms: convales-
cent SARS-CoV-infected patient sera. C0: convalescent patient
serum used as a positive control for S recognition; C2, C3,
C5, C6: convalescent patient sera tested for S recognition. MFI
are indicated for convalescent sera. (b) Soluble recombinant
ACE2 protein was incubated with recombinant S–FLAG protein
pre-adsorbed onto anti-FLAG M2 agarose affinity gel (S–FLAG
IP). Recombinant E. coli BAP–FLAG protein was used as a
negative control (BAP–FLAG IP). Precipitates were separated
by SDS-PAGE followed by Western blot analysis with anti-
ACE2 or anti-FLAG M2 mAbs.
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Our results show that, similarly to other coronaviruses,
individually expressed recombinant SARS-S glycoproteins
can be detected all along the secretory pathway of
mammalian cells, from the ER to the plasma membrane.
SARS-M glycoprotein localizes to the Golgi
apparatus
M proteins of several coronaviruses accumulate in the Golgi
complex of mammalian host cells. In order to analyse the
subcellular localization of SARS-M we performed immuno-
fluorescence analysis on BHK-21 cells expressing M–FLAG,
M–ECFP or M–EGFP fusion proteins previously shown
to have similar distributions (data not shown). At 6 h p.i.,
M proteins were exclusively concentrated in a perinuclear
patch, which colocalizes with a Golgi marker (targeting
sequence of the Golgi b-1,4-galactosyltransferase fused to
EYFP fluorescent tag), but did not colocalize with the
Erp72 ER marker (Fig. 6a, 6 h p.i.). When cells were
analysed at 12 or 15 h p.i. (Fig. 6a and data not shown),
a positive staining for M–EGFP clearly colocalized with
Golgi marker Golgi-58K in the perinuclear area and was
also associated with distinct dots within the cytoplasm,
(Fig. 6a, 12 h p.i.). Golgi localization was confirmed further
by treatment of M-expressing cells with Brefeldin A (BFA),
which induced the complete redistribution of M protein
from the Golgi into the ER (Fig. 6a). M–EGFP partially
colocalized with ERGIC marker, ERGIC-53, within the
Golgi perinuclear area. Moreover, some of the dots posi-
tive for M labelling also merged with ERGIC-53 staining,
suggesting the presence of ERGIC vesicles trafficking
between ER and Golgi. To address better the question of
M trafficking, we performed time-lapse microscopy experi-
ments on living cells expressing M–EGFP (Fig. 6b). Inter-
estingly, starting at 3?5 h p.i., we were able to follow
M–EGFP protein expression, accumulation and trafficking
in living cells. At shortest times, signal for M–EGFP was
weak and only detectable in the Golgi apparatus (Fig. 6b,
see Supplementary material in JGV Online to visualize the
video sequence). Within a few minutes the signal became
brighter showing a strong accumulation of M–EGFP in
the Golgi apparatus. Parallel to the increase in M–EGFP
expression, vesicles moving out of as well as vesicles moving
towards the Golgi apparatus were detected, suggesting an
important M trafficking phenomenon.
These results strongly argue for the accumulation of indi-
vidually expressed SARS-M within the Golgi compartment
and are consistent with our biochemical analyses showing
that M acquires complex N-glycans in the Golgi. They
also show that M protein is transported throughout the
cytoplasm within trafficking vesicles moving towards and
exiting the Golgi apparatus.
SARS-E protein forms large membrane clusters
co-distributing with ER markers
SARS-E protein localization was analysed at 6, 12 and 15 h
p.i.. Fluorescence for E was identified as bright large spots
colocalizing with the Erp72 ERmarker (Fig. 7). However, in
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Fig. 3. SARS-M protein is N-glycosylated and matures within 30 min into an EndoH-resistant complex glycoform. BHK-21
cells were transfected with SARS-M encoding RNA and starved 12 h post-transfection at 37 6C for 30 min in methionine-
and cysteine-free medium. Cells were pulse-labelled for 10 min with 0?3 mCi 35S-labelled methionine and cysteine amino
acids and chased for increasing times before cell lysis. SARS-M proteins were immunoprecipitated with M2 mAb directed
against the FLAG tag and analysed by SDS-PAGE and phosphoimager screen exposure. (a) Cells were chased for 0, 0?5, 1,
3, 6 and 12 h before harvest. (b) Cells were treated as in (a) and immunoprecipitated SARS-M was exposed (+) or not (”) to
EndoH treatment. An arrow on the left of the image shows the band shift caused by EndoH treatment. (c) Cells were treated
as in (a) and immunoprecipitated SARS-M was exposed (+) or not (”) to peptide: N-glycosidase F (PNGaseF) treatment.
Arrows on the right of the image show band shifts caused by PNGaseF treatment. n, Unglycosylated M form; *, EndoH- and
PNGaseF-sensitive M glycoform; #, EndoH-resistant PNGaseF-sensitive M glycoform.
Time (h) 0 0.5 1 3 6
Fig. 4. SARS-E is degraded within 3 h post-synthesis. BHK-
21 cells were transfected with SARS-E encoding RNA and
starved 12 h post-transfection at 37 6C for 30 min in methionine-
and cysteine-free medium. Then, cells were pulse-labelled for
10 min with medium containing 0?3 mCi 35S-labelled methio-
nine and cysteine amino acids and chased for 0–6 h before
lysis, SARS-E immunoprecipitation with M2 anti-FLAG mAb
SDS-PAGE and phosphoimager exposure.
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contrast to SARS-S, -E did not distribute with a typical
ER-type pattern. Furthermore, in E-expressing cells, Erp72
staining no longer appeared with a usual reticulated ER
pattern. When E-expressing cells were treated for 1 or 3 h
with cycloheximide, which inhibits all eukaryotic protein
synthesis, E labelling was strongly reduced confirming our
biochemical evidence that E has a short half-life (data not
shown).
DISCUSSION
Post-translational modifications, folding, oligomerization
and cellular trafficking of viral structural proteins are keys
to viral protein maturation and correct assembly of infec-
tious virion particles. In this report, we used C-terminally
tagged recombinant proteins to show that SARS-CoV
surface proteins S, M and E present differential properties
of expression, maturation kinetics, subcellular localization
and stability, which could regulate viral protein assembly
and virus budding.
In the present study, we show the SARS-S glycoprotein
maturation kinetics, oligomerization, receptor binding and
reactivity with SARS patient sera. Coronavirus S surface
proteins are highly glycosylated trimers (Luo et al., 1999),
which mediate virus entry through binding to specific
cellular receptors (Delmas et al., 1992; Williams et al., 1991;
Yeager et al., 1992). SARS-S uses dendritic cell C-type lectin
DC-SIGN for capture and transmission to target cells (Yang
et al., 2004b) and ACE2 for entry into host cells (Hofmann
et al., 2004a; Li et al., 2003; Wang et al., 2004; Wong et al.,
2004).
SARS-S protein contains 23 putative N-glycosylation sites,
among which 12 have been described to be effectively
glycosylated (Krokhin et al., 2003; Ying et al., 2004). Our
data provide evidence that SARS-S protein, when expressed
alone, acquires EndoH-resistant complex N-glycans in the
Golgi within 30 min following expression. We detected
both high-mannose and complex glycan N-glycoforms on
S trimers within ER and Golgi, respectively. This result
suggests that trimers form in the ER and pass the quality
control to move towards the Golgi to acquire complex
N-glycans. Proteolytic cleavage of surface glycoproteins by
host proteases is required for viruses with class I fusion
proteins, e.g. orthomyxoviruses, paramyxoviruses, retro-
viruses and filoviruses, to make the envelope fusogenic.
Cleavage of MHV-S membrane glycoprotein into S1 and S2
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Fig. 5. SARS-S is localized along the
secretory pathway from the ER to the
plasma membrane. BHK-21 cells were
grown on glass coverslips for 24 h preced-
ing infection with recombinant SFV particles
for (FLAG or GFP)-tagged S expression.
Cells were harvested at indicated times p.i.
and labelled with the corresponding anti-
bodies. Erp72, ER marker; ERGIC-53,
marker for the ER-Golgi intermediate com-
partment; Golgi-58K, Golgi marker.
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subunits enhances fusion activity (de Haan et al., 2004;
Taguchi et al., 1993), even if, depending on the MHV
strain, MHV-S can be fusogenic without proteolytic
cleavage (Taguchi, 1993). It was recently suggested that a
~100 kDa S protein fragment observed in recombinant
His-tagged S-expressing cells might represent S2 subunit
or cross-reacting bands (Simmons et al., 2004; Xiao et al.,
2004). Although we also detected polypeptides with an
apparent molecular mass close to the one expected for S2,
they were found to be unstable in pulse-chase experiments
suggesting that they represent degradation products of
improperly folded S-protein precursors.
We show that SARS-S glycoprotein is present all along the
secretory pathway from the ER to the plasma membrane.
Our pulse-chase experiments combined with EndoH
sensitivity assays show that although the majority of S
had reached or passed through the Golgi, S could still be
detected within the ER. Our results are in accordance with
previous studies that described coronavirus S glycoprotein
within the ER and at the cell surface. MHV-59 S glyco-
protein has been observed predominantly in the ER with
additional intense fluorescence in the Golgi perinuclear
region where M localizes (Opstelten et al., 1993). Recently, a
C-terminal di-lysine motif in group 3 IBV coronaviruses
and a di-basic motif in group 1 coronaviruses and SARS-
CoV have been implicated in S localization within the ER
(Lontok et al., 2004). SARS-S has also been shown at the
cell surface by several groups where it mediates cell-to-cell
fusion (Hofmann et al., 2004b; Simmons et al., 2004). We
also observed a punctate SARS-S staining within the cyto-
plasm of expressing cells. An interesting issue would be to
determine if these vesicles belong to the endosomal system.
Correctly folded oligomeric SARS-S glycoprotein interacts
with its entry receptor ACE2 in vitro and can be recognized
by SARS patient sera. Previous studies showed that anti-S
antibodies could neutralize virus infectivity (Buchholz et al.,
2004; Bukreyev et al., 2004; Sui et al., 2004; Xiao et al., 2003;
Yang et al., 2004a). Purified SARS-S glycoprotein is there-
fore an ideal antigen to develop a safe vaccine against SARS-
CoV, as well as a tool for serodiagnosis.
Coronavirus M protein is the most abundant structural
protein at the surface of virus particles. In group 2
coronaviruses, e.g. MHV and human CoV-OC43 M is O-
glycosylated while in group 1 and 3 coronaviruses, e.g.
TGEV, FIPV and human CoV-229E M is N-glycosylated
(Klumperman et al., 1994; Niemann et al., 1984; Stern &
Sefton, 1982). M is both N- and O-glycosylated in IBV
(Klumperman et al., 1994). Here, we show that SARS-M
protein is N- but not O-glycosylated in mammalian cells.
Coronavirus M glycoprotein is responsible for the induc-
tion of IFN-a in leukocytes (Baudoux et al., 1998a).
Interestingly this interferogenic activity depends on the
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Fig. 6. SARS-M localizes within the Golgi apparatus and in trafficking vesicles throughout the cytoplasm. (a) Confocal
microscopy experiments on BHK-21 cells expressing tagged SARS-M protein. BHK-21 cells were grown on glass coverslips.
Upper panels: cells were transfected with a plasmid construct encoding a Golgi marker consisting in the targeting sequence
of the Golgi b-1,4-galactosyltransferase (GT) fused to EYFP tag. All panels: cells were grown for 24 h prior to infection with
recombinant SFV particles for (ECFP or FLAG)-tagged M expression. Cells were harvested at indicated times p.i. and labelled
with the corresponding antibodies. Erp72, ER marker; ERGIC-53, marker for the ER-Golgi intermediate compartment; Golgi-
58K, Golgi marker. (b) Time-lapse microscopy experiment on BHK-21 cells expressing M–EGFP. BHK-21 cells were grown
on glass bottom microwell-Petri dishes for 24 h prior to infection with recombinant SFV particles for M–EGFP expression.
Images were taken at 3?5 h p.i. and five snapshots out of a sequence of 550 are shown. Snapshot numbers are indicated at
the bottom right side of each image and movements of trafficking vesicles out of the Golgi are indicated by arrows (see
Supplementary material in JGV Online to visualize the video sequence).
6 h p.i.
15 h p.i.
E Erp72 merge
Fig. 7. Subcellular localization of SARS-E
protein. BHK-21 cells were grown on glass
coverslips for 24 h preceding infection with
recombinant E–FLAG SFV particles. Cells
were harvested at indicated times p.i. and
labelled with antibodies against Erp72 ER
marker and FLAG tag.
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FIGURE
http://vir.sgmjournals.org 9
SARS-CoV surface protein maturation
glycosylation status of M, with N-glycosylated M of MHV
being more interferogenic than O- or un-glycosylated M
(de Haan et al., 2003). It is not known whether SARS-M
protein induces IFN-a and whether high-mannose or
complex glycans are involved in this process.
The ERGIC is the budding site for coronaviruses
(Klumperman et al., 1994). Individually expressed corona-
virus M proteins have already been described to concentrate
within the Golgi apparatus (Klumperman et al., 1994;
Locker et al., 1992). Depending on the virus strain, the
precise distribution of M differs, i.e. IBV- and MHV-M
proteins are retained in cis- and trans-Golgi, respectively
(Locker et al., 1995; Machamer et al., 1990; Swift &
Machamer, 1991). Our data indicate that C-terminally
tagged SARS-M glycoprotein strongly colocalizes with Golgi
markers and partially with the ERGIC-53 protein, a lectin
which cycles between ER, ERGIC and cis-Golgi (Appenzeller
et al., 1999). Mature SARS-M proteins carrying complex
N-glycans may have to engage into retrograde transport
from the Golgi apparatus to the ER or ERGIC in order to
attain the budding site, phenomenon already described
for MHV- and IBV-M (de Haan et al., 2000; Maceyka &
Machamer, 1997). Notably, time-lapse microscopy studies
on living cells expressing SARS-M allowed us to identify
vesicles, which traffic out of the Golgi compartment while
no plasma membrane labelling was detected. Although
we cannot exclude a Golgi retention defect caused by the
C-terminal tag, other mechanisms are most likely respon-
sible for this trafficking: M retrograde transport from Golgi
to ER or M transport to the plasma membrane associated
to highly efficient endocytosis and recycling.
Although E protein is only found at low levels in corona-
virus envelope, it has a pivotal role in virus assembly
(Corse & Machamer, 2000, 2002; Fischer et al., 1998; Lim
& Liu, 2001). Previous studies have demonstrated that the
formation of virus-like particles solely depends on the co-
expression of both M and E proteins (Vennema et al., 1996).
Here, we show that individually expressed SARS-E enve-
lope protein has a half-life of 30 min and is no longer
detectable at 6 h post-synthesis. A previous report showed
that coronavirus MHV-E protein stability is comparable
with that of the small envelope glycoprotein (Gs), a minor
virion component of equine arteritis virus, which was
found earlier to be prone to degradation (de Vries et al.,
1995; Raamsman et al., 2000). Those data suggest that
E could be regulated at a post-translational level. The
mechanism involved in E degradation and the potential
implication of this phenomenon in E protein level regula-
tion remain unknown. The two close bands observed for
SARS-E may correspond to a post-translational modifica-
tion event. Based on the evidence that IBV-E protein has
been shown to be palmitoylated (Corse &Machamer, 2002),
albeit results differ in MHV and TGEV (Godet et al., 1992;
Raamsman et al., 2000; Yu et al., 1994), palmitoylation may
occur in one or more of the three cysteine residues of SARS-
E protein, which were predicted to be juxtamembranous
(Arbely et al., 2004). Moreover, it was speculated that
palmitoylation could play a role in the membrane curvature
induction by SARS-E protein. Our immunofluorescence
analysis shows that SARS-E protein concentrates in bright
perinuclear clusters co-labelling with Erp72 ER marker.
However, the distribution of Erp72 no longer displays
its usual ER tubo-reticular profile when co-expressed with
E. Consistently, MHV E has been described to have a
peculiar punctate staining pattern by immunofluorescence
and to induce the formation of electron-dense structures
(Raamsman et al., 2000). It was proposed that those
structures consist of masses of tubular, smooth membranes
with much curvature that are part of the ERGIC and form
networks in continuity with the ER.
In this study, we used C-terminally tagged SARS-CoV viral
proteins and we are confident, based on our observations,
which corroborate anterior studies, that the tags did not
influence SARS-S, -M and -E maturation steps and sub-
cellular localizations.
Altogether, our findings are consistent with previous data
on coronavirus S, M and E protein biogenesis, maturation
process and subcellular distribution and establish a basis
in understanding the intrinsic biochemical properties of
SARS-CoV surface proteins. Future studies will have to
address the issues of regulation of differential maturation
and the role of viral proteins, the cellular partners and
pathways underlying SARS-CoV assembly and budding.
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